USPTO serial 79451556
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lawrence J. Crain
Lawrence J. Crain Greer, Burns & Crain, Ltd.200 West Madison StreetSuite 2100Chicago, IL 60606| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Consulting with respect to custom manufacturing of medication and biological products | ACTIVE | — |
| 042 | Pharmaceutical drug development services; Pharmaceutical research and development; scientific laboratory services; scientific and technological services, namely, biological research and analysis; scientific research and scientific research services in the field of the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient expression of proteins; scientific research services for others in the field of biochemistry; design and development of computer hardware and software; development and research of new products for others; product development for others; product development consultation; product research and development; information technology consulting; computer software consulting; technological consulting concerning computer hardware and software systems to facilitate their selection, implementation and use; custom engineering services for others in the field of chemical and biological process engineering and facility engineering; computer technological services aimed at creating custom manufacturing capacity, technologies, market selection and portfolio mix for the life sciences and pharmaceutical industries; computer technological services aimed at creating scientific, technological and digital ecosystems for third parties in the life sciences and pharmaceutical industries | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2026 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 30, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 30, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 18, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 3, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 21, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 15, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 15, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 14, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 13, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 12, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |